Health & Medical Archives | Page 26 of 242 | Be Korea-savvy

Archive by category Health & Medical

London Research & Pharmaceuticals Presents the Advancement of LRP-661, Their Oral Cannabidiol Sulphate Drug Candidate at the Prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII Conference in Miami

London Research & Pharmaceuticals Presents the Advancement of LRP-661, Their Oral Cannabidiol Sulphate Drug Candidate at the Prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII Conference in Miami

LONDON, Ontario, April 15, 2024 (Korea Bizwire) – London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and predictable PK parameters. CBDS maintains improved oral formulation capabilities vs cannabidiol, including tablet and water-based solutions. When compared against the currently available oral solution [...]

Ascom Signed a 5-year Framework Contract with Istekki in Finland

Ascom Signed a 5-year Framework Contract with Istekki in Finland

Baar, Switzerland, April 11, 2024 (Korea Bizwire) –  Ascom, a global leader in healthcare communication and workflow solutions, has signed a comprehensive framework agreement with Istekki, a significant Finnish healthcare organization. The 5-year agreement has an estimated volume of EUR 6 million and includes the installation of nurse call systems in acute and long-term care [...]

Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs

Novotech Publishes Research Report on Acute Myeloid Leukaemia Clinical Trial Landscape for Clinical Stage Biotechs

BOSTON, Apr. 10 (Korea Bizwire) — Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an expert report, Acute Myeloid Leukaemia – Global Clinical Trial Landscape, offering critical data-backed analysis of the latest developments in Acute Myeloid [...]

Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV

Wistar Scientists Identify Pro-aging ‘Sugar Signature’ in the Blood of People Living with HIV

The Abdel-Mohsen lab findings shed light on how sugar molecules in the blood of people living with HIV may accelerate biological aging PHILADELPHIA, PA, April 10, 2024 (Korea Bizwire) – The Wistar Institute’s associate professor Mohamed Abdel-Mohsen, Ph.D., along with his team and collaborators, has identified sugar abnormalities in the blood that may promote biological aging and [...]

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA and Philips Respironics have now reached final agreement on the consent decree with the DOJ and FDA. As previously stated: The consent decree primarily focuses on Philips Respironics’ business operations in the US. [...]

Essential Pharma Acquires Renaissance Pharma Ltd with Its Clinical Stage Immunotherapy for the Treatment of Hhigh-risk Neuroblastoma

Essential Pharma Acquires Renaissance Pharma Ltd with Its Clinical Stage Immunotherapy for the Treatment of Hhigh-risk Neuroblastoma

Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma First development-stage asset to be added to the Essential Pharma portfolio and second product within rare disease Egham, UK – 9 April 2024 (Korea Bizwire) – Essential Pharma, an international specialty pharma group focused on ensuring that patients have [...]

ASICS Global Study Shows Link Between Regular Exercise in Teenage Years and Positive Mental Wellbeing in Adulthood

ASICS Global Study Shows Link Between Regular Exercise in Teenage Years and Positive Mental Wellbeing in Adulthood

Global ASICS study of 26,000 people reaffirms the connection between movement and the mind and uncovers a direct link between teenage physical activity and adult mental wellbeing Each additional year a teenager remains engaged in exercise is associated with improved State of Mind scores in adulthood, with the ages of 15-17 identified as the most [...]

Smith+Nephew Signs Exclusive Distribution Agreement to Provide Unique NAVBIT SPRINT™ Solution in Australia

Smith+Nephew Signs Exclusive Distribution Agreement to Provide Unique NAVBIT SPRINT™ Solution in Australia

Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Hull, Apr. 8 (Korea Bizwire) – Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney. A single-use, sterile [...]

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

VANCOUVER, British Columbia, April 08, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced five presentations including new data from its preclinical development-stage programs at the 2024 American Association for Cancer Research (AACR) [...]

Curium Plans to Significantly Expand Lutetium-177 Capacity and Pet Footprint With Agreement to Acquire Eczacibaşi-Monrol

Curium Plans to Significantly Expand Lutetium-177 Capacity and Pet Footprint With Agreement to Acquire Eczacibaşi-Monrol

The proposed acquisition of Eczacıbaşı-Monrol will: Build on existing partnership in Lu-177 creating a leading manufacturer of the isotope Add 12 PET sites to Curium’s existing network in geographies where Curium is not present today Add SPECT manufacturing capabilities and extensive logistics infrastructure to Curium Benefit patients with strengthened reliability for diagnostic and therapeutic solutions [...]